Exploratory Study of the Effect of Omega-3-acid Ethyl Esters on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Acronyms Oasis Flow
- Sponsors Takeda Pharma
- 12 Mar 2020 Results investigating the effects of omega-3 on vascular endothelial function, measured by FMD in patients with dyslipidemia, published in the Advances in Therapy
- 25 Aug 2017 Status changed from active, no longer recruiting to completed.
- 04 Jul 2017 Planned primary completion date changed from 1 Aug 2017 to 31 Aug 2017.